DX News
Dynex Capital, Inc.
$9.96
-$0.46(-4.41%)
51
Overall
100
Value
10
Tech
44
Quality
Market Cap
$2.59B
Volume
8.17M
52W Range
$10.31 - $14.93
Target Price
$13.10
DX news: the latest Dynex Capital, Inc. headlines, press releases and market updates, newest first.
Latest DX News
- Invesco QQQ Trust ETF Resists Pressure as Nvidia CEO Resigns — Here’s WhySolomon Oladipupo · Nov 12, 2026
- Neurosterix Closes $105 Million Series B FinancingTipRanks Switzerland Auto-Generated Newsdesk · Nov 11, 2026
- COSCO SHIPPING Energy Transportation Announces 16-VLCC CharterTipRanks HongKong Auto-Generated Newsdesk · Nov 11, 2026
- Audax Renovables Registers Corporate Website Domain TransferTipRanks Spain Auto-Generated Newsdesk · Nov 11, 2026
- J.P. Morgan Remains a Buy on JCDecaux SA (0MGO)TipRanks Auto-Generated Intelligence Newsdesk · Nov 11, 2026
- Director Jayne Shaw Acquires 72,315 BCAL Diagnostics SharesTipRanks Australian Auto-Generated Newsdesk · Nov 11, 2026
- Dexus Industria REIT Provides Final Distribution DetailsTipRanks Australian Auto-Generated Newsdesk · Nov 10, 2026
- DXN Awarded Approximately A$4.8m Modular Cable Landing Station ContractTipRanks Australian Auto-Generated Newsdesk · Nov 10, 2026
- Invesco QQQ Trust ETF Is Falling Today, Nov. 10 — Here’s WhySolomon Oladipupo · Nov 10, 2026
- Codexis Secures New Financing and Repays Prior LoanTipRanks Auto-Generated Newsdesk · Nov 10, 2026
- Audax Renovables Announces Planned Q3 2026 Results DateTipRanks Spain Auto-Generated Newsdesk · Nov 10, 2026
- ADX Energy Announces Ineligible Shareholder Treatment Under Entitlement OfferTipRanks Australian Auto-Generated Newsdesk · Nov 9, 2026
- ADX Energy Announces 2-for-5 Offer Targeting Up to $5.2 MillionTipRanks Australian Auto-Generated Newsdesk · Nov 9, 2026
- ADX Opens Rights Issue Seeking Up to $5.2 MillionTipRanks Australian Auto-Generated Newsdesk · Nov 9, 2026
- Syndax Pharmaceuticals (SNDX) Shareholder Investigation: MAXPIRe Trial Runs Out of Breath as Axatilimab Misses Its MarkJoseph E. Levi · Nov 9, 2026
- Guggenheim Keeps Their Buy Rating on Celldex (CLDX)TipRanks Auto-Generated Intelligence Newsdesk · Nov 9, 2026
- UBS Keeps Their Buy Rating on Becton Dickinson (BDX)TipRanks Auto-Generated Intelligence Newsdesk · Nov 9, 2026
- U.S. Chess Champion Has ETFs XLE and TSXD to Thank as Portfolio Remains PositiveDavid Craik · Nov 9, 2026
- Goldman Sachs Sticks to Its Buy Rating for Nordex (NRDXF)TipRanks Auto-Generated Intelligence Newsdesk · Nov 9, 2026
- Analysts Offer Insights on Industrial Goods Companies: Global Payments (GPN), Nordex (OtherNRDXF) and Karman Holdings Inc. (KRMN)TipRanks Newsroom · Nov 9, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DX | $9.96 | -4.4% | 8.17M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |